Midterm Outcomes of Shoulder Dislocations in Brachial Plexus Birth Injuries Treated With Injection Botulinum Toxin A

Maulin M Shah1, Joyance J Mammen2, Meet Jain2

  • 1Department of Pediatric Orthopedics, Orthokids Clinic.

PubMed

Insights

Botulinum toxin A injections effectively treat infantile shoulder dislocations by relieving internal rotation contractures. However, this treatment may lead to external rotation contractures in children with C7 muscle involvement.

Area of Science:

  • Pediatric Orthopedics
  • Neuromuscular Disorders

Background:

  • Infantile shoulder dislocation is a recognized condition diagnosed via ultrasound.
  • Botulinum toxin A injections can be an adjunct therapy for internal rotation contractures in shoulder dislocations.

Purpose of the Study:

  • To evaluate intermediate-term outcomes of shoulder dislocations treated with botulinum toxin A injections.
  • To identify factors influencing the success of this treatment.

Main Methods:

  • Eighty-six children with ultrasound-diagnosed shoulder dislocation received botulinum toxin A injections.
  • Sixty-two children were followed for a mean of 36 months, assessing the Hospital for Sick Children Active Movement Scale (HSC-AMS) and range of motion.
  • Injections targeted the subscapularis and pectoralis major muscles, followed by stretching and casting.

Main Results:

  • 44% of children required no further surgery (Group A).
  • 44% experienced recurrence of internal rotation contracture (Group B).
  • 12% developed external rotation contracture (Group C), associated with C7 muscle involvement.

Conclusions:

  • Botulinum toxin A is effective for shoulder dislocations with early C5-C6 muscle recruitment.
  • Avoid this procedure in children with C7 muscle involvement due to the risk of external rotation contracture.
Abstract